RELATION OF COVERT VISCERAL ADIPOSITY AND SUBCLINICAL ATHEROSCLEROSIS PRESENTATION IN TYPE 2 DIABETES MALE PATIENTS
https://doi.org/10.15829/1728-8800-2018-1-49-53
Abstract
Aim. To evaluate the prevalence of covert visceral adiposity (CVA) in males with type 2 diabetes (DM2) and to assess its relation with subclinical atherosclerosis and food-related behavior.
Material and methods. To the study, 72 middle age males included (54,1±0,7 y.o.). Mean duration of DM25,1±1,1 years. In 28 patients DM2 had been diagnosed first time in the study. Those with body mass index (BMI) >30 kg/m2 and waist circumference >102 cm were excluded. All patients underwent standard clinical investigations and additionally, leptin levels measurement in blood serum, with bioelectrical impedance measurement of adipous tissue amount, duplex scan of carotid and femoral arteries; the EAT-26 questionnaire was applied.
Results. In the group of participants, CVA prevalence was 31%. In this group of patients there were significantly higher BMI, waist circumference low density lipoproteides levels and leptin. At atherosclerosis assessment in carotid and femoral arteries, CVA associated with more significant and multifocal lesion. In regression analysis, the sum of plaques number correlated with the age, BMI, systolic blood pressure, low density lipoproteides levels.
Conclusion. CVA might have significance in the increase of cardiovascular risk in middle aged males with normal BMI and with no obesity.About the Authors
A. Е. Filippov
Saint-Petersburg State University
Russian Federation
Russian Federation
A. A. Sergoventsev
P. V. Mandryka Central Military Clinical Hospital of the Ministry of Defense
Russian Federation
Russian Federation
Moscow
B. V. Pomogaibo
413 Military Hospital of the Ministry of Defense
Russian Federation
Russian Federation
Volgograd
References
1. World Health Organization. Obesity and overweight. WHO Fact Sheet. 2013; 301 (update April 2017). http://www.who.int/mediacentre/factsheets/fs311/en/ (10 May 2017).
2. Carnethon MR, De Chavez PJ, Biggs ML, et al. Association of weight status with mortality in adults with incident diabetes. JAMA 2012; 308: 581-90. DOI: 10.1001/jama.2012.9282.
3. Annand S, Yusuf S, Hawken S, et al. Risk factors for myocardial infarction in women and men: insights from the INTERHEART Study. Eur Heart J 2008; 29: 932-40. DOI: 10.1093/eurheartj/ehn018.
4. Recommendations of the experts of Russian Scientific Society of Cardiologists of diagnosis and treatment of metabolic syndrome. Second revision. Prev Med 2010; 5: 83-101. (in Russ.) Рекомендации экспертов Всероссийского научного общества кардиологов по диагностике и лечению метаболического синдрома. Второй пересмотр. Профилактическая медицина 2010; 5: 83-101.
5. Mi S, Yin P, Hu N, et al. BMI, WC, WHtR, VFI and BFI: which indicator is the most efficient screening index in type 2 diabetes in Chinese community population. Biomed Environ Sci 2013; 26: 485-91. DOI: 10.3967/0895-3988.2013.06.009.
6. Pimentel J, Moreto F, Takahashi M, et al. Sagital abdominal diameter, but not waist circumference is strongly associated with glycemia, triacilglycerols and HDL-C levels in overweight adults. Eur J Nutr Hosp 2011; 26: 1125-9. DOI: 10.1590/S0212-16112011000500031.
7. Van Gaal LF, Mertens IL, De Block CE. Mechanisms linking obesity with cardiovascular disease. Nature 2006; 444: 875-80. DOI: 10.1038/nature05487.
8. Romero-Corral A, Somers VK, Sierra-Johnson J, et al. Normal weight obesity: a risk factor for cardiometabolic dysregularion and cardiovascular mortality. Eur Heart J 2010; 31: 737-46. DOI: 10.1093/eurheartj/ehp487.
9. Beck E, Scheen A. Metabolically obese with normal weight individuals: an intriguing phenotype. Rev Med Liege 2009; 64: 16-24.
10. Oliveros E, Somers VK, Sochor O, et al. The concept of normal weight obesity. Prog Cardiovasc Dis 2014; 56: 426-33. DOI: 10.1016/j.pcad.2013.10.003.
11. Rivas T, Bersabe R, Jimenez M, et al. The Eating Attitudes Test (EAT-26): reliability and validity in Spanish female samples. Span J Psycol 2010; 13: 1044-56.
12. Facuda S, Hirata A, Nashizawa H, et al. Systemic arteriosclerosis and eating behavior in Japanese type 2 diabetic patients with visceral fat accumulation. Cardiovascular Diabetology 2015; 14: 8. DOI: 10.1186/s12933-015-0174-7.
13. Kim S, Kyung C, Park JS, et al. Normal-weight obesity is associated with increased risk of subclinical atherosclerosis. Cardiovascular Diabetology 2015; 14: 58. DOI: 10.1186/s12933-015-0220-5.
14. Browning LM, Muqridqe O, Dixon A, et al. Measuring abdominal adipose tissue: comparison of simpler methods with MRI. Obes Facts 2011; 4: 9-15. DOI: 10.1159/000324546.
15. Sahakyan KR, Somers VK, Rodriquez-Escudero JP, et al. Normal-weight central obesity: implications for total and cardiovascular mortality. Ann Intern Med 2015; 163: 827-35. DOI: 10.7326/M14-2525.
16. Cornier MA, Despres JP, Davis N, et al. Assessing adiposity. A scientific statement from the American Heart Association. Circulation 2011; 124: 1996-2019. DOI: 10.1161/CIR.0b013e318233bc6a.
17. Rao G, Powell-Wiley TM, Ancheta I, et al. Identification of obesity and cardiovascular risk in ethnically and racially diverse populations. A scientific statement from the American Heart Association. Circulation 2015; 132: 457-72. DOI: 10.1161/CIR.0000000000000223.
Review
For citations:
Filippov A.Е., Sergoventsev A.A., Pomogaibo B.V. RELATION OF COVERT VISCERAL ADIPOSITY AND SUBCLINICAL ATHEROSCLEROSIS PRESENTATION IN TYPE 2 DIABETES MALE PATIENTS. Cardiovascular Therapy and Prevention. 2018;17(1):49-53. (In Russ.) https://doi.org/10.15829/1728-8800-2018-1-49-53
Views:
891
Email this article 
